This paper is part of larger efforts to promote greater disclosure in medical product litigation. For additional resources, please see our recent conference report: (7/9)
And also, this is among the many reasons me and others convened a multi-stakeholder group to oppose confidentiality orders in medical product litigation; many of the sealed docs are relevant to public health